GSK
740 hedge funds and large institutions have $11.7B invested in GSK in 2015 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 324 increasing their positions, 231 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.05% less ownership
Funds ownership: 4.18% → 4.13% (-0.05%)
43% less call options, than puts
Call options by funds: $123M | Put options by funds: $215M
45% less capital invested
Capital invested by funds: $21.1B → $11.7B (-$9.42B)
Holders
740
Holding in Top 10
9
Calls
$123M
Puts
$215M
Top Buyers
| 1 | +$231M | |
| 2 | +$56.6M | |
| 3 | +$52M | |
| 4 |
SCCM
Schafer Cullen Capital Management
New York
|
+$50.9M |
| 5 |
SM
Seminole Management
New York
|
+$48.9M |
Top Sellers
| 1 | -$203M | |
| 2 | -$157M | |
| 3 | -$126M | |
| 4 |
Jane Street
New York
|
-$83.6M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$81.1M |